Advertisement

author_dummy.png

BW Online Bureau

BW Online Bureau

Latest Articles By BW Online Bureau

1560327995_0nkj1i_sanitary_pad_shutterstock_470.jpg

Prioritising Menstrual Health Critical To India’s Growth Story

Menstrual Health Investment Index is a mere 1.2 per cent of India’s GDP per capita, while disposable period products are unaffordable for a large section of the population. India can, however, make significant economic gains to its GDP by 2.7 per cent, by addressing period poverty

Read More
1585206698_aMjms2_2020_03_26T064900Z_1_LYNXMPEG2P0D3_RTROPTP_3_NOVARTIS_SWISS_FACTORY.JPG

EU Regulator Seeks To Revoke Authorisation Of Novartis Sickle Cell Drug

The European Medicines Agency (EMA) said on Friday it had recommended revoking marketing authorisation for Novartis' sickle cell disease drug Adakveo

Read More
1503045568_mQtX2K_ASTER_DM_HEALTHCARE_LOGO.jpg

Aster DM Investors Eye USD 300 Mn Stake Sale In India Business

Investors in Aster DM Healthcare are in talks to sell a 30 per cent stake in the company's India business for about USD 300 million, two sources with direct knowledge said, the latest potential deal in India's booming healthcare sector

Read More
1486549291_P3Mg3N_Rs2000notes-PTI.jpg

Govt. Clears Supplementary Outlay Under NHM For Maharashtra

Under National Health Mission (NHM) to strengthen the healthcare systems, the ministry has approved additional new posts for public health specialists, medical officers, staff nurses and other staff in Maharashtra

Read More
1685194123_ISV66J_Picture1.png

Standard Quality & Affordable Manufacturing With Focus On R&D: Mandaviya On Leveraging Pharma

Mandaviya urged the stakeholders to capitalize on the current opportunities, stating “substantial investment in terms of Production Linked Incentive schemes as well as upcoming drug parks are bearing fruitful results.

Read More
1608271800_0mv5Yy_COVID_19_Vaccine.jpg

EU, Pfizer/BioNTech Amend Covid Vaccine Contract

The original contract was signed in May 2021 and committed the EU to buy 900 million doses from Pfizer/BioNTech, with an option for an additional 900 million, by the end of 2023

Read More

BW Columnists